As we discuss later, [dopaminergic](https://neurohacker.com/what-is-dopamine) drugs are often used to treat schizophrenia, so schizophrenia-linked genes that affect the dopamine system, such as those that code for the D2 dopamine receptor and the enzyme [catechol-O-methyltransferase (COMT)](https://en.wikipedia.org/wiki/Catechol-O-methyltransferase) have been of special interest. Some studies suggest that individual differences in the COMT gene, which influences dopamine metabolism, may contribute to cognitive function in both normal and schizophrenic patients. For example, in combined samples of normal and schizophrenic people, a particular COMT gene variant, the val genotype, predicts poorer performance on tasks of frontal lobe function (Egan et al., 2001), as well as more deficient sensory filtering (Lu et al., 2007). However, because individual differences in the COMT gene have not been consistently linked to the presence of schizophrenia (Ripke et al., 2014), it is unclear whether the COMT gene plays a role in causing the disorder, or whether its role is better understood as making certain cognitive symptoms worse among those who already have the condition. These nuances illustrate the complexity of attempting to relate individual gene variants to complex clinical conditions.

正如我们随后要讨论的，多巴胺能药物通常被用来治疗精神分裂症，因此精神分裂症相关的基因影响多巴胺系统，例如编码D2多巴胺受体和儿茶酚-O-甲基转移酶（COMT）的基因一直是科学家们特别有兴趣的基因。一些研究表明，影响多巴胺代谢的COMT基因的个体差异可能有助于理解正常和精神分裂症患者的认知功能的差异。例如，在正常和精神分裂症患者的组合样本中，特定的COMT基因变体val基因型预测了对有关额叶功能任务更差表现，以及更缺乏的对所感觉到的信息的过滤（Lu et al。，2007）。然而，由于COMT基因的个体差异并没有一致地与精神分裂症的存在相关联，尚不清楚COMT基因是否在引起该疾病中起作用，或者其作用是否随着已经患有这种疾病的人的某些认知症状恶化而得到更好的了解。这些细微差别说明了试图将个体基因变异与复杂的临床病症联系起来的复杂性。

One framework for thinking about the etiology of schizophrenia is the neurodevelopmental hypothesis. This hypothesis argues that neural connectivity and biochemical function are altered in subtle ways from an early age, leaving the individual with a vulnerable neural organization (Brent et al., 2013; Rapoport et al., 2005). According to this hypothesis, the disorder will become “unmasked” later in life, after puberty or at the onset of young adulthood. The unmasking is thought to occur because of some combination of adverse or stressful environmental conditions, the increased demand placed on the brain by the broader repertoire of behaviors required in adulthood, and maturational changes in the brain during adolescence and young adulthood.

为了探究精神分裂症病因的一个框架是神经发育假说。这一假说认为神经连接和生物化学功能从早期就以微妙的方式改变，使个体具有脆弱的神经组织。根据这一假设，这种疾病将在生命后期，青春期后或成年后开始“揭开面纱”。暴发疾病被认为是由于某些不利或压力环境条件的复合，该复合是由于成年和在青春期和青年时期的发育变化导致的更多全面的行为需要，大脑需要更多的地方所致。

Supporting the neurodevelopmental hypothesis, studies have found that people with schizophrenia have minor physical anomalies (associated with atypical prenatal development), cognitive and neurologic deficits that precede the first psychotic episode, a family history of difficult births, exposure to viruses in utero, and anatomical brain abnormalities in both the formation of brain structure and cellular organization (Brent et al., 2013; Rapoport et al., 2005). All of these findings implicate an abnormal developmental process that precedes the first onset of schizophrenic symptoms.

支持神经发育假说的研究发现患有精神分裂症的人具有轻微的身体异常（与不同寻常的产前发育有关），在第一次精神病发作之前的认知和神经缺陷，难产的家族史，暴露于子宫内的病毒以及解剖上脑结构和细胞组织形成的大脑异常。所有这些发现都暗示了精神分裂症症状首次发作之前的异常发育过程。

